Browse by Journal Title

2020

Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial.
Bröckelmann, P.J. and Goergen, H. and Keller, U. and Meissner, J. and Ordemann, R. and Halbsguth, T.V. and Sasse, S. and Sökler, M. and Kerkhoff, A. and Mathas, S. and Hüttmann, A. and Bormann, M. and Zimmermann, A. and Mettler, J. and Fuchs, M. and von Tresckow, B. and Baues, C. and Rosenwald, A. and Klapper, W. and Kobe, C. and Borchmann, P. and Engert, A.
JAMA Oncology 6 (6): 872-880. June 2020

Association of germline variant status with therapy response in high-risk early-stage breast cancer: a secondary analysis of the GeparOcto randomized clinical trial.
Pohl-Rescigno, E. and Hauke, J. and Loibl, S. and Möbus, V. and Denkert, C. and Fasching, P.A. and Kayali, M. and Ernst, C. and Weber-Lassalle, N. and Hanusch, C. and Tesch, H. and Müller, V. and Altmüller, J. and Thiele, H. and Untch, M. and Lübbe, K. and Nürnberg, P. and Rhiem, K. and Furlanetto, J. and Lederer, B. and Jackisch, C. and Nekljudova, V. and Schmutzler, R.K. and Schneeweiss, A. and Hahnen, E.
JAMA Oncology 6 (5): 744-748. May 2020

2017

Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: secondary analysis of the GeparSixto randomized clinical trial.
Hahnen, E. and Lederer, B. and Hauke, J. and Loibl, S. and Kröber, S. and Schneeweiss, A. and Denkert, C. and Fasching, P.A. and Blohmer, J.U. and Jackisch, C. and Paepke, S. and Gerber, B. and Kümmel, S. and Schem, C. and Neidhardt, G. and Huober, J. and Rhiem, K. and Costa, S. and Altmüller, J. and Hanusch, C. and Thiele, H. and Müller, V. and Nürnberg, P. and Karn, T. and Nekljudova, V. and Untch, M. and von Minckwitz, G. and Schmutzler, R.K.
JAMA Oncology 3 (10): 1378-1385. 1 October 2017

Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer.
Neidhardt, G. and Hauke, J. and Ramser, J. and Groß, E. and Gehrig, A. and Müller, C.R. and Kahlert, A.K. and Hackmann, K. and Honisch, E. and Niederacher, D. and Heilmann-Heimbach, S. and Franke, A. and Lieb, W. and Thiele, H. and Altmüller, J. and Nürnberg, P. and Klaschik, K. and Ernst, C. and Ditsch, N. and Jessen, F. and Ramirez, A. and Wappenschmidt, B. and Engel, C. and Rhiem, K. and Meindl, A. and Schmutzler, R.K. and Hahnen, Eric
JAMA Oncology 3 (9): 1245-1248. 1 September 2017